FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY FEMORAL HEAD

MDR report key: 2894519 · Received January 3, 2013

Report

Report Number
1818910-2013-10135
Event Type
Injury
Date Received
January 3, 2013
Date of Event
December 6, 2012
Report Date
December 6, 2012
Manufacturer
DEPUY INTL., LTD.
Product Code
KXA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. A SEARCH OF THE COMPLAINT DATABASE AND/OR DHR REVIEW WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODE REQUIRED WAS NOT PROVIDED. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT WITH THE INFORMATION AVAILABLE. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ANY ADDITIONAL INFORMATION BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A SEARCH OF THE COMPLAINT DATABASE AND/OR DHR REVIEW WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODES REQUIRED WERE NOT PROVIDED. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT WITH THE INFORMATION AVAILABLE. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

LITIGATION ALLEGES THAT THE PATIENT SUFFERS FROM FRICTION WEAR BETWEEN THE COBALT CHROMIUM METAL HEAD AND COBALT CHROMIUM METAL LINER, WHICH HAS CAUSED SEVERE PAIN, DISCOMFORT, AND TROUBLE WALKING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2621 UNKNOWN DEPUY FEMORAL HEAD FEMORAL HEAD KXA DEPUY INTL., LTD. UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 67 YR Other